Collectively, these studies indicate that TGF-α plays a crucial role in the pathogenesis of ocular complications of T2D, and targeted intervention against TGF-α emerges as an appealing therapeutic strategy for diabetic retinopathy. Here, TGFA is linked to type 2 diabetes mellitus.